FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Hetero Labs, Ltd. - Unit III Aripiprazole Tablets Recall

Aripiprazole Tablets, USP, 10 mg, 30-count bottles, Rx Only, Manufactured for Camber P…

Hetero Labs, Ltd. - Unit III · Hyderabad, N/A

Risk level
Class II
Reported by FDA
Feb 14, 2018
Recall ID
D-0594-2018
Check your lot numberHow we source this data

Summary

Hetero Labs, Ltd. - Unit III recalled Aripiprazole Tablets starting Jan 10, 2018. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0594-2018 on Feb 14, 2018. Reason: CGMP Deviations: lot made with active pharmaceutical ingredient that did not meet all its intended specifications. Status: Terminated.

Why it was recalled

CGMP Deviations: lot made with active pharmaceutical ingredient that did not meet all its intended specifications.

Product description

Aripiprazole Tablets, USP, 10 mg, 30-count bottles, Rx Only, Manufactured for Camber Pharmaceuticals, Inc. Piscataway, NJ 08854, By; Hetero Hetero Labs Limited Unit V Polepallly Jadcheria Mahaboob Nagar - 509 301 India, NDC 31722-827-30

Lot numbers, UPCs & expiration codes

Lot #: ARI17089, ARI17090, Exp. 5/2019

Where it was sold

NJ Only

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0594-2018
Classification
Class II
Status
Terminated
Recall initiated
Jan 10, 2018
FDA report date
Feb 14, 2018
Quantity
3000 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Hetero Labs, Ltd. - Unit III

Original FDA data

Every field from FDA enforcement report D-0594-2018, exactly as published.

Show all FDA fields
City
Hyderabad
Status
Terminated
Country
India
Event ID
78809
Address
Plot 22-110, Part Ii, Ida
Address (line 2)
Rangareddy, Jeedimetla
Code information
Lot #: ARI17089, ARI17090, Exp. 5/2019
Report date
Feb 14, 2018
Product type
Drugs
Recall number
D-0594-2018
Classification
Class II
Recalling firm
Hetero Labs, Ltd. - Unit III
Product quantity
3000 bottles
Termination date
Sep 21, 2020
Reason for recall
CGMP Deviations: lot made with active pharmaceutical ingredient that did not meet all its intended specifications.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Aripiprazole Tablets, USP, 10 mg, 30-count bottles, Rx Only, Manufactured for Camber Pharmaceuticals, Inc. Piscataway, NJ 08854, By; Hetero Hetero Labs Limited Unit V Polepallly Jadcheria Mahaboob Nagar - 509 301 India, NDC 31722-827-30
Distribution pattern
NJ Only
Recall initiation date
Jan 10, 2018
Initial firm notification
Letter
Center classification date
Mar 13, 2018

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0594-2018, published Feb 14, 2018. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls